Skip to main content

Mark E. Boulding

Equibles does not estimate personal net worth.

Get an email with a short summary when Ptc Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get PTCT alerts

About Mark E. Boulding

Mark E. Boulding is recorded as General Counsel at Ptc Therapeutics, Inc. (PTCT). The newest filing on record that lists Mark E. Boulding as General Counsel at Ptc Therapeutics, Inc. (PTCT) is dated April 27, 2020. The proxy statement of Ptc Therapeutics, Inc. reports total compensation of $2,509,994 for Mark E. Boulding in fiscal 2019, including a base salary of $475,000. Disclosed compensation is on record for 3 fiscal years. Ptc Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ptc Therapeutics, Inc. includes Dr. Matthew B. Klein (CEO and Board Member), Matthew B. Klein (CEO and Board Member), Matthew Klein (CEO and Board Member) and 7 others.

Affiliation history

Company network

Leadership on record at Ptc Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2019 Ptc Therapeutics, Inc. (PTCT) $475,000 $2,509,994
2018 Ptc Therapeutics, Inc. (PTCT) $434,120 $1,604,903
2017 Ptc Therapeutics, Inc. (PTCT) $434,120 $1,121,909

Recent activity

No call appearances or filed executive changes recorded yet.